FENC Fennec Pharmaceuticals Inc.

22h ago, source: Seeking Alpha

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript

27d ago, source: InvestingChannel on MSN

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript March 21, 2024 Fennec Pharmaceuticals Inc. isn't ...

Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up

1mon ago, source: Zacks.com on MSN

Fennec Pharmaceuticals Inc. FENC announced that it has entered into an exclusive licensing deal with Norgine, a European ...

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

28d ago, source: Business Insider

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the fiscal year ended December 31, 2023 and provided a business ...

Fennec Pharmaceuticals Inc FENC

2d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Q4 2023 Fennec Pharmaceuticals Inc Earnings Call

27d ago, source: Yahoo Finance

Robert Andrade; CFO; Fennec Pharmaceuticals Inc. Rosty Raykov; CEO & Director; Fennec Pharmaceuticals Inc. Adrian Haigh; COO; Fennec Pharmaceuticals Inc. Noreen ...

Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

28d ago, source: Finanznachrichten

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the fiscal year ended December 31, 2023 and provided a business ...

Fennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call Transcript

27d ago, source: Seeking Alpha

Good morning, ladies and gentlemen. And welcome to the Fennec Pharmaceuticals' Fourth Quarter and Full Year 2023 Earnings and Corporate Update Conference Call. At this time, all participants are ...

Fennec Pharmaceuticals Inc FENC

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript

27d ago, source: Insider Monkey

Fennec Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen.